Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.92 USD | +7.02% | +3.45% | -21.88% |
May. 30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
May. 20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.88% | 2B | |
+26.34% | 88.08B | |
-24.01% | 75.32B | |
+3.45% | 28.19B | |
+7.05% | 17.78B | |
-13.33% | 16.64B | |
+0.81% | 15.64B | |
+80.21% | 13.81B | |
-26.67% | 13.01B | |
+23.39% | 12.43B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating